Cita APA (7a ed.)

VW, Z., AB, S., SM, A., & SI, O. (2019). Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification. Dove Medical Press.

Cita Chicago Style (17a ed.)

VW, Zhu, Schrock AB, Ali SM, y Ou SI. Differential Response to a Combination of Full-dose Osimertinib and Crizotinib in a Patient with EGFR-mutant Non-small Cell Lung Cancer and Emergent MET Amplification. Dove Medical Press, 2019.

Cita MLA (8a ed.)

VW, Zhu, et al. Differential Response to a Combination of Full-dose Osimertinib and Crizotinib in a Patient with EGFR-mutant Non-small Cell Lung Cancer and Emergent MET Amplification. Dove Medical Press, 2019.